Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.40% | 1.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.40% | 1.88% | |||
| Cost of Revenue | 11.37% | 0.71% | |||
| Gross Profit | 6.63% | 2.59% | |||
| SG&A Expenses | 14.47% | 0.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.49% | 0.19% | |||
| Operating Income | -13.46% | 11.99% | |||
| Income Before Tax | -9.90% | 22.80% | |||
| Income Tax Expenses | -28.12% | 25.03% | |||
| Earnings from Continuing Operations | -4.11% | 22.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -493.83% | 139.90% | |||
| Net Income | -5.64% | 23.68% | |||
| EBIT | -13.46% | 11.99% | |||
| EBITDA | -13.32% | 10.27% | |||
| EPS Basic | -3.33% | 20.00% | |||
| Normalized Basic EPS | -9.70% | 21.03% | |||
| EPS Diluted | -3.33% | 20.00% | |||
| Normalized Diluted EPS | -9.70% | 21.03% | |||
| Average Basic Shares Outstanding | -2.39% | 3.07% | |||
| Average Diluted Shares Outstanding | -2.39% | 3.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||